The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients

OBJECTIVE: Although the tumor mutation burden (TMB) was reported as a biomarker for immunotherapy of various cancers, whether it can effectively predict the survival prognosis in breast cancer patients remains unclear. In this study, the prognostic value of TMB and its correlation with immune infilt...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Shengjin, Feng, Jingying, Tang, Xi, Lou, Shuang, Guo, Weiquan, Xiao, Xiaowei, Li, Shuping, Chen, Xue, Huan, Yu, Zhou, Yiwen, Xiao, Lijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940352/
https://www.ncbi.nlm.nih.gov/pubmed/36805828
http://dx.doi.org/10.1186/s40001-023-01058-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940352/
https://www.ncbi.nlm.nih.gov/pubmed/36805828
http://dx.doi.org/10.1186/s40001-023-01058-x

Ejemplares similares